CERAD, The Consortium to Establish a Registry for Alzheimer’s Disease
 
CERAD Clinical and Neuropsychology Assessment

This Clinical Assessment Packet consists of a battery of brief evaluations designed to gather demographic, clinical, neurological and neuropsychological data on cognitively impaired subjects, sufficient to establish a clinical diagnosis of dementia based on CERAD criteria.

Table of contents of CERAD Protocol 5: Assessment Packet for Probable Alzheimer’s Disease (AD):

A. DEMOGRAPHIC DATA:
    SUBJECT
B. DEMOGRAPHIC DATA:
  INFORMANT
C. CLINICAL HISTORY
  C1 Clinical History
       A) Cognitive Impairment/Dementia
B) Systemic Illnesses
C) Cerebrovascular Disease
D) Parkinson’s Disease
E) Depression
F) Drug Effects
  C2 Blessed Dementia Scale (ADL)
C3 Behavior Rating Scale
C4 Short Blessed Test
C5 Calculation, Clock and Language
D. CLINICAL EXAMINATIONS
  D1 Physical Examination
D2 Neurologic Examination
E. LABORATORY AND IMAGING STUDIES
  A) Clinical laboratory studies
B) Neuroimaging studies
F. CLINICAL DIAGNOSIS
      F1 CDR Staging
  F2 Diagnostic Impression
       A) Cognitive Function Normal
    B) Impaired Cognition
  F3 Diagnostic Impression
    A) Alzheimer’s Disease
    B) AD with Other Illness
    C) Other Disorders
J. NEUROPSYCHOLOGICAL FORMS
  J0 Summary of J Tests
  J1 Verbal Fluency
  J2 Boston Naming Test
  J3 Mini-mental State Exam
  J4 Word List Memory
  J5 Constructional Praxis
  J6 Word List Recall
  J7 Word List Recognition
  J8 Recall of Constructional Praxis

 

 





Download Printable version of this page.


Center for the Study of Aging and Human Development, Duke University Medical Center

Copyright © 2005